Peptide Synthesis Global Market Report 2024

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The increase observed in the historical period can be attributed to the rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, increased demand for high-purity peptides, and the impact of regulatory approvals and standardization efforts.

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The anticipated growth in the forecast period can be attributed to the rapid expansion of therapeutic peptides, an increasing demand for customized peptides, a growing role in drug discovery and development, and a focus on peptide libraries for screening. Major trends expected in the forecast period involve the development of peptide mimetics, the adoption of novel amino acid derivatives, advancements in peptide cyclization techniques, innovations in solid-phase peptide synthesis (SPPS), and the utilization of click chemistry.

The anticipated surge in chronic diseases is poised to drive the growth of the peptide synthesis market. Chronic diseases, characterized by long-term health conditions that progress gradually, are a significant focus for peptide synthesis due to the potential of certain peptides to exhibit anti-inflammatory and antioxidant properties. This capability positions peptides as potential contributors to the prevention of chronic diseases, including cardiovascular conditions. Peptides, by targeting specific cellular processes and signaling pathways, offer novel therapeutic and management options for addressing the root causes of chronic diseases. For example, the British Heart Foundation reported in August 2023 an increase in deaths attributed to coronary heart disease in the UK, rising from 64,170 in 2020 to 65,579 in 2021. Hence, the escalating prevalence of chronic diseases is a key factor propelling the growth of the peptide synthesis market.

The growth in healthcare expenditure is expected to further fuel the expansion of the peptide synthesis market. Healthcare expenditure, encompassing financial resources allocated to medical treatments, healthcare services, and public health initiatives, plays a pivotal role. The pharmaceutical and nutrition industries allocate substantial expenditures to peptide molecules due to their therapeutic potential, specificity, and low toxicity. In May 2023, the Office for National Statistics revealed that the UK government spent £233.1 billion on healthcare, marking a 9.4% increase in nominal terms and a 9.6% increase in real terms. This continued growth in government spending, following a historic surge of 13.5% in real terms in 2020, underscores the role of healthcare expenditures in driving the growth of the peptide synthesis market.

The high cost of instruments poses a potential challenge and may impede the market's growth during the forecast period. Acquiring and maintaining essential appliances, including rapid, high-throughput systems, peptide synthesizers, and chromatography equipment, can be cost-prohibitive for researchers and companies entering the peptide synthesis market, particularly those with limited budgets or resources. For example, in 2023, Biotage reported that new peptide synthesizer systems could range from $30,000 to $200,000 and beyond, depending on factors such as software flexibility and synthesis scale capability. Consequently, the high cost of instruments represents a hindrance to the growth of the peptide synthesis market.

Major companies in the peptide synthesis market are strategically focusing on introducing advanced peptide synthesizers to gain a competitive edge. Notably, Gyros Protein Technologies launched the PurePep Sonata+ peptide synthesizer in March 2022, offering enhanced efficiency, speed, and accuracy compared to traditional synthesizers. This innovative technology incorporates real-time flow monitoring, ensuring precise and accurate fluid transfers across a diverse range of viscosities.

In May 2023, Biosynth International, Inc., a Swiss-based chemical manufacturing company, acquired Cambridge Research Biochemicals to strengthen its peptide division. This acquisition brings CRB's expertise in intricate peptide chemistry and fluorescent dye labeling, enhancing Biosynth's capabilities in the peptide synthesis market.

Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix.

North America was the largest region in the peptide synthesis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The primary types of products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are chemical compounds or substances used in the creation of peptides. Various technologies are employed in this process, including solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid and recombinant technology. These products and services are utilized by several end-users, including pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs) and contract research organizations (CROs), as well as academic and research institutes.

The peptide synthesis market research report is one of a series of new reports that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 1-3 business days.